What exactly was so exciting about Monsanto's (NYSE: MON) earnings release yesterday that justified a nearly 10% jump in the stock price? After all, the company said just last week how much it thought it would make in the quarter and it hit its guidance for earnings per share on the nose at $3.64 for the fiscal year. The company did come in a little higher than expected for its GAAP EPS, but should we really be all that excited about the company underestimating charges associated with buying De Ruiter's vegetable seed business and selling its Posilac cow hormone to Eli Lilly (NYSE: LLY)? Big hint: No! Then again, a 10% gain doesn't look like all that much when Monsanto is still well off its 52-week high set last June. In fact the entire agriculture industry has been severely hurt by lower grain prices. Source: Yahoo! Finance....
[read full story]
Your Web Site
